Early Identification of Cardiac Involvement in Patients With Carcinoid: Clinical and Prognostic Implications
Conditions: Neuroendocrine Tumors Interventions: Other: Evaluation of blood levels of biomarkers of cardiac damage Sponsors: European Institute of Oncology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors
Conditions: Neuroendocrine Tumors; Neuroendocrine Tumor of the Lung; Neuroendocrine Tumor of Pancreas; Neuroendocrine Carcinoma Metastatic; Neuroendocrine Tumor Carcinoid; Carcinoid Tumor of GI System; Carcinoid Tumor; Paraganglioma; Pheochromocytoma Intervention: Drug: [212Pb]VMT-α-NET, Sponsor: Viewpoint Molecular Targeting Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2022 Category: Research Source Type: clinical trials
Study of RYZ101 Compared With SOC in Pts With Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
Conditions: GEP-NET; Gastroenteropancreatic Neuroendocrine Tumor; Gastroenteropancreatic Neuroendocrine Tumor Disease; Neuroendocrine Tumors; Carcinoid; Carcinoid Tumor; Pancreatic NET Interventions: Drug: RYZ101; Drug: Everolimus 10 mg; Drug: Sunitinib 37.5 MG; Drug: Octreotide LAR 60 MG Injection; Drug: Lanreotide 120Mg Sa Susp Inj Syringe Sponsor: RayzeBio, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2022 Category: Research Source Type: clinical trials
